BMC Medical Co., Ltd. (SHE:301367)
40.39
-0.79 (-1.92%)
Jun 17, 2026, 4:00 PM EDT
BMC Medical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, BMC Medical stock has a consensus rating of "Strong Buy" and an average price target of ¥69.29. The average 1-year stock price forecast is 71.55% higher than the current stock price, while the lowest is ¥60.00 (+48.55%) and the highest is ¥78.57 (+94.53%).
Price Target: ¥69.29 (+71.55%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BMC Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Oct '25 | Nov '25 | Jan '26 | Apr '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
1.44B
from 1.16B
Increased by 24.59%
Revenue Next Year
1.70B
from 1.44B
Increased by 17.83%
EPS This Year
2.64
EPS Next Year
n/a
from 2.64
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5B | ||
| Avg | 1.4B | ||
| Low | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 29.3% | ||
| Avg | 24.6% | ||
| Low | 19.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 2.64 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 255.8% | ||
| Low | - |